Uncategorized
Gene variants in AMD may predict 3-year outcomes with PDT
Variants of the ARMS2 gene may be associated with the results of photodynamic therapy in wet age-related macular degeneration, according to a study.The 65 patients included in the study were recruited from the ophthalmology department at Kobe University Hospital in Japan. All patients had previously taken part in a study evaluating the 12-month outcomes of PDT in wet AMD between 2005 and 2008. As the authors noted, anti-VEGF agents were not available in Japan at the time and PDT was commonly used to treat AMD. In addition, PDT is still (Read more...)